Good MorningInvestors got a dose of good news with Thursday's CPI report. The data was cooler than expected on a month-to-month and year-over-year basis, aligning with the expectation that the FOMC would cut rates at least once this year. The data from the CME suggests two cuts are possible by December, which is now the hope.
The bad news is that the CPI data was a sell-the-news event. The S&P 500 surged initially but opened weakly and moved lower throughout the day, closing with a loss of nearly 1%. The silver lining is that the S&P 500 is extended and needs a periodic correction to alleviate overbought conditions. This means the pullback, should it deepen, is reasonable considering the long-term outlook and should result in a buying opportunity soon. Featured: The Midterm Trap That Could Ruin Your 401(k) (Ad) 
|
Consumer Staples | |
WD-40 Company (NASDAQ: WDFC) is a healthy, value-building company whose stock price has struggled, providing ample opportunities for investors to buy in. Hurdles remain, including high interest and inflation, but the stock price is set to rise over the coming quarters and is on track to set a new ... Read the Full Story |
|
From Our Partners | | Every morning before the market opens, a scanner called Oracle runs through 15,000 stocks and scores the setups — so there's already a plan in place by 6:15 a.m.
Lead Trainer Tim Bohen of StocksToTrade is walking through exactly how Oracle works and how regular traders are using it in a training running right now. | | Watch the Oracle training now and see how the scanner works |
|
Technology | |
Investors will find that most of the market’s attention has centered on today's technology sector, particularly stocks dealing with artificial intelligence and its growing adoption throughout the global economy. For better reference, investors can dig into the VanEck Semiconductor ETF (NASDA... Read the Full Story |
|
Consumer Staples | |
PepsiCo (NASDAQ: PEP) shares have struggled with traction for the last two years as inflation, pricing pressure, consumer pushback, and economic headwinds impact results, but those days will soon end. The latest CPI report shows inflation cooling faster than expected and has the FOMC on track to... Read the Full Story |
|
From Our Partners | | Tomorrow morning, a small group of investors will receive a text alert tied to what may be the most powerful stock rating software in the world - and every message it has sent has averaged a gain of 310 percent, including the misses.
Members of this exclusive list have seen nearly 3,000 chances to double their money and over 400 chances to 10x it. The next alert goes out as early as 9:30 a.m. | | Learn how to sign up and receive the next alert today |
|
Consumer Discretionary | |
Six Flags Entertainment (NYSE: SIX) announced last week the successful completion of its merger with Cedar Fair (NYSE: FUN). The merger of these two firms in the consumer discretionary sector creates one of the largest theme park operators in North America. It will compete with firms such as the W... Read the Full Story |
|
Medical | |
The healthcare industry represents a substantial and dynamic market sector, presenting many opportunities for investors seeking long-term growth and stability. Factors such as the aging population, technological advances, and rising healthcare costs provide the sector with a compelling combination... Read the Full Story |
|
From Our Partners | | With OpenAI and Anthropic moving closer to the IPO spotlight, AI excitement could spill into several public-market sectors this summer - and most investors may chase the obvious names too late.
A free report identifies 7 stocks positioned around themes that could matter most this summer: AI infrastructure, energy demand, travel, entertainment, home improvement, and more. Built for a market where leadership may rotate quickly. | | Download 7 Best Stocks to Own in Summer 2026 for free |
|
Financial Services | |
The financial sector, and specifically the sector ETF Financial Select Sector SPDR Fund (NYSE: XLF), has been consolidating for several months and is now approaching a significant breakout level.
As earnings season kicks off, the sector's major players are set to report quarterly results, potent... Read the Full Story |
|
Consumer Discretionary | |
Some investors gravitate towards controversial market plays, attracted by the significant upside potential. Albemarle Co. (NYSE: ALB) deserves attention today, especially after its 34% drop since May 2024. Despite recent discouraging price action, the fundamentals of this company may signal a pote... Read the Full Story |
|
Transportation | |
Delta Air Lines (NYSE: DAL) shares lost their lift following the Q2 release, but investors should not worry. The results were weaker than expected, including decelerating growth and rising costs, but they align with the long-term outlook. The long-term outlook is for steady, normalized growth an... Read the Full Story |
|
Markets | | A dividend cut occurs when a company decides to reduce the amount that it pays out in dividends. There are many reasons why a company might do this, including financial hardship, debt reduction, or funding for new ventures. Read on to learn more about dividend cuts, what they mean, and what you may ... Read the Full Story |
|
Retail/Wholesale | |
If you have watched Kura Sushi USA (NASDAQ: KRUS) and are waiting for a good time to buy, this is it. The company is a high-quality restaurant player, growing at a solid double-digit pace, but faces headwinds impacting the share price. The headwinds are cyclical and will recede; when they do, th... Read the Full Story |
|
Friday's Early Bird Stock Of The Day ProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic kidney diseases in the United States. The company's lead product is Renal Autologous Cell Therapy (REACT), an autologous homologous cell admixture, which has completed Phase I clinical trial for REACT in patients with congenital anomalies of the Kidney and Urinary Tract (CAKUT), as well as in Phase III and Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease. ProKidney Corp. founded in 2015 and is headquartered in Winston-Salem, North Carolina. | | View Today's Stock Pick |
|
